BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Saturday, April 20, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 12, 2020
View Archived Issues
Prying mantis identifies disease genes
Read More
T-cell mutations contribute to GvHD
Read More
TLR5 is a therapeutic target for treating chronic colonic hypersensibility
Read More
NIH initiates ACTT 2 study of remdesivir plus baricitinib in patients with COVID-19
Read More
Novel peptide-targeted approach improves potency of anticancer drugs
Read More
PK and PD data presented for OPL-002 in healthy volunteers
Read More
CPU-025 demonstrates promising efficacy in mouse model of diabetes
Read More
Array BioPharma discloses new PTPN11 inhibitors
Read More
Dana-Farber Cancer Institute, Voronoi patent wild-type and mutant LRRK2 inhibitors
Read More
New histone-lysine N-methyltransferase SMYD3 inhibitors identified at Epizyme
Read More
Wild-type and mutant RET inhibitors identified at Medshine Discovery
Read More
Dual adenosine A2A/A2B receptor antagonists described by Merck KGaA
Read More
Via gene therapy, follistatin fights fat's fallout
Read More
New POLG genetic variant found in SANDO syndrome
Read More
ONSET-2 trial of OC-01 in dry eye disease meets primary endpoint
Read More
Phase III study of mavacamten in obstructive hypertrophic cardiomyopathy meets endpoints
Read More
Kiniksa reports data on mavrilimumab for COVID-19 and vixarelimab for pruritus
Read More
Boehringer Ingelheim studies BI-456906 for type 2 diabetes in new phase II trial
Read More
Canakinumab studied in phase III for CRS in patients with COVID-19-induced pneumonia
Read More
Enrollment underway for first-in-human study of BRAF inhibitor ABM-1310 in advanced solid tumors
Read More
Ustekinumab efficacy demonstrated in pediatric Crohn's disease patients
Read More
Phase I study of BRD4 inhibitor SYHA-1801 begins for advanced solid tumors
Read More
FDA clears IND for phase Ib/IIa study of HST-001 for androgenic alopecia
Read More
Phase III study of Sarclisa in relapsed multiple myeloma meets primary endpoint
Read More
Genfit reports phase III interim data on elafibranor in NASH
Read More